04/13/2023 - Dr. Vineeta Goel - Radiation Oncology - India SBRT Lung
Chartrounds India - SBRT
•
41m
mutation positive NSCLC, CNS metastases, immunogenic tumour, tumor, TKI, IO, chemotherapy, radiation therapy, tumor biology, non-small cell lung cancer, brain metastases, SRS, radiation necrosis, lung molecular graded prognostic assessment, GPA, adenocarcinoma, ALK mutated NSCLC, ALK rearrangement, liquid biopsy, TKI generations, immunotherapy, crizotinib, alectinib, brigatinib, PFS, BICR, lorlatinib, ALK toxicities, survival rates, MRI features, RT, BBB, enhancing lesion, ALK/EGFR and NSCLC is a distinct biological subtype, sanctuary site, symptomatic and progressive brain mets, avoid WBRT, prefer SRS/SRT, asymptomatic BM, gefitinib, erlotinib, afatinib, icotinib, osimertinib
Up Next in Chartrounds India - SBRT
-
07/27/2023 - Dr. Indranil Mallick - R...
-
India SBRT Lung Sayan Paul August 10 ...
-
09/28/2023 - Elaine Zeman, PhD - Radi...
radiobiology, electromagnetic radiation, biological systems, ionizing radiations, mutations, growth delay and disturbance, whole body radiation syndrome, teratogenesis, subcellular level, signal transduction, DNA damage and repair, cellular circuitry, proliferation, hallmarks, immortalization, te...
